Robert Burns
Stock Analyst at HC Wainwright & Co.
(0.90)
# 3,647
Out of 4,829 analysts
497
Total ratings
23.75%
Success rate
-22.52%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORIC ORIC Pharmaceuticals | Maintains: Buy | $21 → $22 | $5.43 | +305.53% | 24 | May 9, 2025 | |
| CRDF Cardiff Oncology | Maintains: Buy | $17 → $18 | $2.75 | +554.55% | 2 | May 9, 2025 | |
| PRLD Prelude Therapeutics | Reiterates: Buy | $5 | $0.88 | +465.23% | 16 | May 5, 2025 | |
| SWTX SpringWorks Therapeutics | Downgrades: Neutral | $74 → $47 | $46.12 | +1.91% | 32 | Apr 30, 2025 | |
| CRBU Caribou Biosciences | Maintains: Buy | $9 → $3 | $0.82 | +266.70% | 14 | Apr 28, 2025 | |
| TNGX Tango Therapeutics | Reiterates: Buy | $13 | $1.31 | +892.37% | 12 | Apr 14, 2025 | |
| BCAX Bicara Therapeutics | Maintains: Buy | $45 → $44 | $14.19 | +210.08% | 3 | Apr 7, 2025 | |
| HURA TuHURA Biosciences | Maintains: Buy | $13 → $12 | $3.83 | +213.32% | 2 | Apr 3, 2025 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $36 | $10.18 | +253.63% | 15 | Apr 2, 2025 | |
| ELTX Elicio Therapeutics | Reiterates: Buy | $10 | $5.52 | +81.16% | 7 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $97.27 | +49.07% | 38 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.33 | +503.77% | 21 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.51 | +298.41% | 3 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $36.98 | +8.17% | 7 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $2 | $1.59 | +26.18% | 21 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $12 | $4.07 | +194.84% | 20 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $39 | $18.99 | +105.37% | 3 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.86 | +478.70% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $1.17 | +583.76% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $12 | $1.75 | +585.71% | 13 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $1.95 | +1,643.59% | 3 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $13 | $12.05 | +7.93% | 20 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.15 | +366.20% | 14 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $1.36 | +267.65% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.11 | +414.47% | 21 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $39 | $20.06 | +94.42% | 8 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $41.88 | +74.31% | 19 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $7.86 | +179.90% | 16 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.08 | +236.54% | 7 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.08 | - | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $6.45 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $5.12 | +173.44% | 10 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $1.19 | +824.37% | 13 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.25 | $0.73 | +207.80% | 10 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $5.43 | +3,580.73% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $20 | $0.44 | +4,406.53% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.62 | - | 6 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $2.30 | +6,421.74% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $1.15 | +1,813.04% | 4 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $1.07 | +554.21% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $2.13 | +416.43% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $225 | $0.04 | +562,400.00% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $4.08 | +512.75% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.35 | +862.96% | 1 | Jan 7, 2021 |
ORIC Pharmaceuticals
May 9, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $5.43
Upside: +305.53%
Cardiff Oncology
May 9, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $2.75
Upside: +554.55%
Prelude Therapeutics
May 5, 2025
Reiterates: Buy
Price Target: $5
Current: $0.88
Upside: +465.23%
SpringWorks Therapeutics
Apr 30, 2025
Downgrades: Neutral
Price Target: $74 → $47
Current: $46.12
Upside: +1.91%
Caribou Biosciences
Apr 28, 2025
Maintains: Buy
Price Target: $9 → $3
Current: $0.82
Upside: +266.70%
Tango Therapeutics
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $1.31
Upside: +892.37%
Bicara Therapeutics
Apr 7, 2025
Maintains: Buy
Price Target: $45 → $44
Current: $14.19
Upside: +210.08%
TuHURA Biosciences
Apr 3, 2025
Maintains: Buy
Price Target: $13 → $12
Current: $3.83
Upside: +213.32%
Nurix Therapeutics
Apr 2, 2025
Reiterates: Buy
Price Target: $36
Current: $10.18
Upside: +253.63%
Elicio Therapeutics
Apr 2, 2025
Reiterates: Buy
Price Target: $10
Current: $5.52
Upside: +81.16%
Apr 1, 2025
Maintains: Buy
Price Target: $150 → $145
Current: $97.27
Upside: +49.07%
Mar 31, 2025
Reiterates: Buy
Price Target: $8
Current: $1.33
Upside: +503.77%
Mar 31, 2025
Reiterates: Buy
Price Target: $10
Current: $2.51
Upside: +298.41%
Mar 27, 2025
Reiterates: Buy
Price Target: $40
Current: $36.98
Upside: +8.17%
Mar 25, 2025
Maintains: Neutral
Price Target: $4 → $2
Current: $1.59
Upside: +26.18%
Mar 21, 2025
Maintains: Buy
Price Target: $22 → $12
Current: $4.07
Upside: +194.84%
Mar 21, 2025
Maintains: Buy
Price Target: $37 → $39
Current: $18.99
Upside: +105.37%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $0.86
Upside: +478.70%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.17
Upside: +583.76%
Mar 18, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $1.75
Upside: +585.71%
Mar 18, 2025
Maintains: Buy
Price Target: $40 → $34
Current: $1.95
Upside: +1,643.59%
Mar 10, 2025
Maintains: Neutral
Price Target: $12 → $13
Current: $12.05
Upside: +7.93%
Mar 10, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $2.15
Upside: +366.20%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.36
Upside: +267.65%
Mar 7, 2025
Reiterates: Buy
Price Target: $16
Current: $3.11
Upside: +414.47%
Mar 7, 2025
Reiterates: Buy
Price Target: $39
Current: $20.06
Upside: +94.42%
Mar 3, 2025
Maintains: Buy
Price Target: $72 → $73
Current: $41.88
Upside: +74.31%
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $7.86
Upside: +179.90%
Feb 10, 2025
Reiterates: Buy
Price Target: $7
Current: $2.08
Upside: +236.54%
Jan 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.08
Upside: -
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $6.45
Upside: -
Jan 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $5.12
Upside: +173.44%
Sep 5, 2024
Maintains: Neutral
Price Target: $12 → $11
Current: $1.19
Upside: +824.37%
Aug 19, 2024
Reiterates: Buy
Price Target: $2.25
Current: $0.73
Upside: +207.80%
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $5.43
Upside: +3,580.73%
Mar 21, 2024
Maintains: Buy
Price Target: $110 → $20
Current: $0.44
Upside: +4,406.53%
Jan 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $7.62
Upside: -
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $2.30
Upside: +6,421.74%
Mar 17, 2023
Reiterates: Buy
Price Target: $22
Current: $1.15
Upside: +1,813.04%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $1.07
Upside: +554.21%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $2.13
Upside: +416.43%
Nov 24, 2021
Maintains: Buy
Price Target: $250 → $225
Current: $0.04
Upside: +562,400.00%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $4.08
Upside: +512.75%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.35
Upside: +862.96%